Caris Life Sciences Inc: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Caris Life Sciences Inc Unternehmen

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Caris Life Sciences Inc Informationen



BörsenkürzelCAI

Name des UnternehmensCaris Life Sciences Inc

IPO-datumJun 18, 2025

CEOHalbert (David Dean)

Anzahl der mitarbeiter- -

WertpapierartOrdinary Share

GeschäftsjahresendeJun 18

Addresse750 W. John Carpenter Freeway

StadtIRVING

BörseNASDAQ OMX - NASDAQ BASIC

LandUnited States of America

Postleitzahl75039

Telefon18667718946

Websitehttps://www.carislifesciences.com/

BörsenkürzelCAI

IPO-datumJun 18, 2025

CEOHalbert (David Dean)

Führungskräfte von Caris Life Sciences Inc



Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. George H. Poste, Ph.D.

Vice Chairman of the Board

511.70K

--

Mr. Luke Power

Chief Financial Officer, Senior Vice President, Chief Accounting Officer

163.54K

+39.12%

Mr. David (Dave) Fredrickson

Independent Director

2.49K

--

Mr. David Dean Halbert

Chairman of the Board, Chief Executive Officer, Founder

--

Dr. Jonathan Knowles, Ph.D.

Vice Chairman of the Board

--

Mr. Brian J. Brille

Vice Chairman of the Board, Executive Vice President

--

Dr. David Spetzler, Ph.D.

President

--

Mr. Nathan Burns

Independent Director

--

Mr. Peter M. Castleman

Lead Independent Director

--

Mr. Joseph E. Gilliam

Independent Director

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. George H. Poste, Ph.D.

Vice Chairman of the Board

511.70K

--

Mr. Luke Power

Chief Financial Officer, Senior Vice President, Chief Accounting Officer

163.54K

+39.12%

Mr. David (Dave) Fredrickson

Independent Director

2.49K

--

Mr. David Dean Halbert

Chairman of the Board, Chief Executive Officer, Founder

--

Dr. Jonathan Knowles, Ph.D.

Vice Chairman of the Board

--

Mr. Brian J. Brille

Vice Chairman of the Board, Executive Vice President

--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Nach RegionUSD

Name

Umsatz

Anteil

United States

801.39M

98.69%

International

10.64M

1.31%

Nach Geschäftsbereich

Nach Region

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Thu, May 14

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Halbert (David D)

43.52%

Sixth Street Partners, LLC

6.86%

J.H. Whitney Capital Partners, LLC

6.46%

J. H. Whitney Equity Partners VI, LLC

6.46%

Fidelity Management & Research Company LLC

4.48%

Andere

32.23%

Aktionäre

Anteil

Halbert (David D)

43.52%

Sixth Street Partners, LLC

6.86%

J.H. Whitney Capital Partners, LLC

6.46%

J. H. Whitney Equity Partners VI, LLC

6.46%

Fidelity Management & Research Company LLC

4.48%

Andere

32.23%

Aktionärstypen

Aktionäre

Anteil

Individual Investor

48.53%

Investment Advisor

26.42%

Hedge Fund

13.90%

Private Equity

7.96%

Investment Advisor/Hedge Fund

5.69%

Research Firm

0.93%

Pension Fund

0.60%

Sovereign Wealth Fund

0.04%

Bank and Trust

0.03%

Institutionelle Beteiligung



Aktualisiert: Wed, Apr 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2026Q4

228

134.49M

38.87%

--

2026Q1

348

157.12M

55.58%

+16.76M

2025Q4

261

137.01M

48.56%

+26.69M

2025Q3

172

130.04M

46.09%

+127.36M

2025Q2

45

192.42M

69.23%

+189.87M

2025Q1

3

2.55M

0.92%

+2.55M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Halbert (David D)

123.08M

43.56%

+320.11K

+0.26%

Mar 06, 2026

Sixth Street Partners, LLC

19.39M

6.86%

-5.00M

-20.50%

Dec 31, 2025

J.H. Whitney Capital Partners, LLC

20.26M

7.17%

--

Dec 31, 2025

Fidelity Management & Research Company LLC

12.67M

4.48%

+3.09M

+32.26%

Dec 31, 2025

Castleman Peter M

10.38M

3.67%

+5.51K

+0.05%

Feb 26, 2026

Coatue Management, L.L.C.

9.82M

3.48%

-322.21K

-3.18%

Dec 31, 2025

T. Rowe Price Investment Management, Inc.

9.21M

3.26%

+1.18M

+14.71%

Dec 31, 2025

Braidwell LP

7.82M

2.77%

+500.00K

+6.83%

Dec 31, 2025

PointState Capital LP

6.72M

2.38%

+2.83M

+73.00%

Dec 31, 2025

Verbundene ETFs



Aktualisiert: Sat, Dec 6

Name

Anteil

ARK Genomic Revolution ETF

0.67%

Texas Capital Texas Small Cap Equity Index ETF

0.52%

Renaissance IPO ETF

0.43%

RiverNorth Patriot ETF

0.3%

Franklin Genomic Advancements ETF

0.29%

Invesco Russell 1000 Equal Weight ETF

0.08%

Inspire 500 ETF

0.07%

T Rowe Price Small-Mid Cap ETF

0.05%

Texas Capital Texas Equity Index ETF

0.04%

Fidelity Nasdaq Composite Index ETF

0.02%

ARK Genomic Revolution ETF

Anteil0.67%

Texas Capital Texas Small Cap Equity Index ETF

Anteil0.52%

Renaissance IPO ETF

Anteil0.43%

RiverNorth Patriot ETF

Anteil0.3%

Franklin Genomic Advancements ETF

Anteil0.29%

Invesco Russell 1000 Equal Weight ETF

Anteil0.08%

Inspire 500 ETF

Anteil0.07%

T Rowe Price Small-Mid Cap ETF

Anteil0.05%

Texas Capital Texas Equity Index ETF

Anteil0.04%

Fidelity Nasdaq Composite Index ETF

Anteil0.02%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten